Accueil   Diary - News   All news Debiopharm and BIOASTER join forces to expand research to combat infectious diseases

Debiopharm and BIOASTER join forces to expand research to combat infectious diseases

 

 

Lausanne, Switzerland and Lyon, France – July, 9th, 2019. Debiopharm (www.debiopharm.com), a Swiss biopharmaceutical company, and BIOASTER (www.bioaster.org), the French Technology Research Institute in infectiology and microbiology, announced today having officialized a broad research agreement for the development of diagnostic and management innovation for infectious diseases. This relationship will harness BIOASTER’s scientific and technical expertise, including technology platforms, to support Debiopharm’s breakthrough research programs. Their development efforts are expected to accelerate projects towards industrial product readiness.

 

Read the press release